Pharma / Biotech

High Cost Trips Up Oral Chemotherapy Initiation

Denver—Many patients are abandoning or delaying initiation of their oral oncolytic therapies because of the high cost of the medication, according to the results of a survey of pharmacy staff and administrators presented at the 2018 annual meeting of the Hematology/Oncology Pharmacy Association (poster TR165).

Source link

Related posts

Pharmacokinetic evaluation of marbofloxacin after intravenous administration at different ages in llama crias, and pharmacokinetic/pharmacodynamic analysis by Monte Carlo simulation.


QUIP (Sodium Monofluorophosphate) Paste, Dentifrice [Quip NYC Inc.]


TOPCARE MIGRAINE RELIEF (Acetaminophen, Aspirin, Caffeine) Tablet, Film Coated [Topco Associates LLC]


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World